Par Pharma Shareholders Seek Settlement Approval
Par Pharmaceuticals Co. Inc. agreed Friday to overhaul its accounting practices as part of a proposed settlement to a shareholder derivative suit over losses allegedly incurred from falsified business reports....To view the full article, register now.
Already a subscriber? Click here to view full article